Clinical Trial

LCMS-Based Metabolic Analysis Explores the Effect of American Ginseng on Urine and Plasma in Healthy Individuals

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 26, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Researchers will use LCMS Metabolic Analysis to Explore the Effect of American Ginseng on Urine and Plasma in Healthy Individuals Participants will: * Take 3 grams of American Ginseng powder every day for 14 days * Collect the fasting urine samples at the following times at the hospital: On the first day, on the 7th day after taking the medicine, and on the 14th day after taking the medicine. * Collect the fasting Serum samples at the following times at the hospital: On the first day and on the 14th day after taking the medicine. * Have their any adverse effects monitored and evaluated throughout the study.
Trial Details
NCT Number NCT07252362
Lead Sponsor Zhejiang Cancer Hospital
Conditions The Impact of American Ginseng on the Metabolomics of Urine and Plasma in Healthy Individuals
Enrollment 20 participants
Start Date 2023-11-11
Primary Completion 2025-12-30 (estimated)
Study Completion 2026-03-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-26